These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 30040827)

  • 1. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study.
    Calao M; Wilson JL; Spelman L; Billot L; Rubel D; Watts AD; Jemec GBE
    PLoS One; 2018; 13(7):e0200683. PubMed ID: 30040827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
    Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
    J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
    Garg A; Birabaharan M; Strunk A
    J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation.
    Rondags A; Arends S; Wink FR; Horváth B; Spoorenberg A
    Semin Arthritis Rheum; 2019 Feb; 48(4):611-617. PubMed ID: 29751976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study.
    Deckers IE; Benhadou F; Koldijk MJ; Del Marmol V; Horváth B; Boer J; van der Zee HH; Prens EP
    J Am Acad Dermatol; 2017 Jan; 76(1):49-53. PubMed ID: 27793450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study.
    Theut Riis P; Pedersen OB; Sigsgaard V; Erikstrup C; Paarup HM; Nielsen KR; Burgdorf KS; Hjalgrim H; Rostgaard K; Banasik K; Ullum H; Jemec GB
    Br J Dermatol; 2019 Apr; 180(4):774-781. PubMed ID: 29999187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
    Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
    Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent-Onset Hidradenitis Suppurativa: Prevalence, Risk Factors and Disease Features.
    Molina-Leyva A; Cuenca-Barrales C
    Dermatology; 2019; 235(1):45-50. PubMed ID: 30368494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of metabolic syndrome and hidradenitis suppurativa.
    Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
    JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of body weight on the prevalence and severity of hidradenitis suppurativa.
    Kromann CB; Ibler KS; Kristiansen VB; Jemec GB
    Acta Derm Venereol; 2014 Sep; 94(5):553-7. PubMed ID: 24577555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Population- and Hospital-based Cross-sectional Study of Renal Function in Hidradenitis Suppurativa.
    Miller IM; Carlson N; Mogensen UB; Ellervik C; Jemec GB
    Acta Derm Venereol; 2016 Jan; 96(1):68-71. PubMed ID: 25710874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Hidradenitis Suppurativa in an African Population: Validation of a Screening Questionnaire in Lagos, Nigeria.
    Anaba EL; Bouazzi D; Ajayi PV; Aro OO; Boer J; Jemec GBE
    Dermatology; 2023; 239(5):832-835. PubMed ID: 37343527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
    Shlyankevich J; Chen AJ; Kim GE; Kimball AB
    J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.
    Kokolakis G; Wolk K; Schneider-Burrus S; Kalus S; Barbus S; Gomis-Kleindienst S; Sabat R
    Dermatology; 2020; 236(5):421-430. PubMed ID: 32610312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.
    Esmann S; Dufour DN; Jemec GB
    Br J Dermatol; 2010 Jul; 163(1):102-6. PubMed ID: 20331444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP).
    Delany E; Gormley G; Hughes R; McCarthy S; Kirthi S; Markham T; Tobin AM; Murphy M; Kirby B
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):467-473. PubMed ID: 29125658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates - Italian Registry Hidradenitis Suppurativa project 2.
    Bettoli V; Cazzaniga S; Scuderi V; Zedde P; Di Landro A; Naldi L;
    J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():4-6. PubMed ID: 31535758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidradenitis Suppurativa in Sweden: A Registry-Based Cross-Sectional Study of 13,538 Patients.
    Killasli H; Sartorius K; Emtestam L; Svensson Å
    Dermatology; 2020; 236(4):281-288. PubMed ID: 32015234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic and clinical features of hidradenitis suppurativa in Korea.
    Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH;
    J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Point-of-Care Treatment Decisions for Hidradenitis Suppurativa.
    Garg A; Besen J; Legler A; Lam CS
    JAMA Dermatol; 2016 May; 152(5):553-7. PubMed ID: 26843464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.